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Neuron numbers in developing vertebrate organisms are regulated by the availability of growth factors which promote
their survival. However, neuron survival may also be regulated by growth factors which promote rather than prevent cell
death. This study examined the effects of bone morphogenetic proteins (BMPs) in inducing apoptosis of MAH cells, an
immortalized sympathoadrenal progenitor cell line. Treatment of MAH cells with BMP2 or BMP4 killed the cells in a
dose-dependent manner. By contrast, treatment with BMP7 or TGFb1 failed to affect survival, suggesting that induction
of apoptosis is speci®c to the dpp subgroup of BMPs. Survival after treatment with BMP2 or BMP4 required addition of
®broblast growth factor (FGF) and nerve growth factor (NGF), indicating that BMP treatment made the neurons dependent
upon an exogenous factor for survival. Several experimental observations suggested an apoptotic mechanism for BMP-
induced death. After BMP2 treatment, the cells progressively shrank and became pyknotic. Further, there was prominent
endonucleosomic cleavage of DNA (laddering) as well as TUNEL staining. Moreover, BMP-induced death was inhibited by
the caspase inhibitor z-VAD and was partially prevented by the endonuclease inhibitor aurintricarboxylic acid. These
observations suggest that neuron numbers may be regulated by factors which promote death and that exposure to such
factors may be a signal for the development of dependence upon other growth factors for survival. q 1998 Academic Press
INTRODUCTION 1993). Conversely, grafting of vestibulo-acoustic ectoderm
in place of presumptive nodose ectoderm leads to the gener-
ation of neurons which have long neurites and which sur-In the early embryo, neurons develop independently of
vive for a period of time without neurotrophins. Thus, re-in¯uences of the target organ (Coughlin et al., 1977; Davies,
gional signals acting on presumptive placodal ectoderm1994). However, shortly after neurons innervate their tar-
specify not only a neuronal fate, but also the growth andgets, they become dependent upon target-derived factors,
survival characteristics of the cells. However, while target-and a substantial number undergo programmed cell death
derived signals may not be the sole determinants of the(PCD). Thus, the supply of target-derived growth factors
timing of acquisition of growth factor dependence, they mayregulates the number of neurons, providing a mechanism
play important roles. For example, the onset of dependencefor matching the requirements of the target to its innerva-
on brain-derived neurotrophic factor (BDNF) in early nodosetion. A simple explanation for the coincidental develop-
neurons may be accelerated by premature exposure toment of growth factor dependence and the arrival of out-
BDNF (Vogel and Davies, 1991). This suggests that target-growing ®bers in targets would be that the target provides
derived factors may ®ne-tune intrinsic patterns of growtha suitable signal. However, detailed studies of developing
preprogrammed into the neurons.cranial sensory neurons suggest that neurons possess intrin-
Neuron survival may also be regulated by growth factorssic programs which regulate growth factor dependence inde-
which promote rather than prevent apoptosis. For example,pendent of the arrival of ®bers to their targets (for review see
the cytokine leukemia inhibitory factor (LIF) inducesDavies, 1994). For example, grafting of presumptive nodose
apoptosis of embryonic and neonatal sympathetic neuronsplacodal ectoderm into developing vestibulo-acoustic gan-
in a dose-dependent fashion and increases the requirementglia results in the generation of neurons which elaborate
for nerve growth factor (NGF) for survival (Kessler et al.,short neurites (the vestibular phenotype) and which die rap-
idly in the absence of growth factors (Vogel and Davies, 1993). The proapoptotic actions of LIF are developmentally
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regulated and disappear postnatally (Kessler et al., 1993; (CNTF) collaborates with bFGF to enhance neuronal differ-
entiation of MAH cells (Ip et al., 1994). These observationsKotzbauer et al., 1994). NGF itself may induce rather than
prevent apoptosis in some cells which express the low-af- suggest that the determination of neuronal identity may
involve activation of parallel regulatory pathways and may®nity neurotrophin receptor (p75LNTR) but not one of the
high-af®nity (trk) receptors (Casaccia-Bonne®l et al., 1996; re¯ect the combined effects of multiple epigenetic signals.
Since both neuronal differentiation and the acquisitionFrade et al., 1996). In the chick embryo, bone morphogene-
tic protein 4 (BMP4) is selectively expressed in the dorsal of growth factor dependence are induced by the regional
microenvironment of progenitor cells, it is possible that theregions of odd-numbered rhombomeres (r3 and r5) and in-
duces segmental apoptosis within these regions (Graham same signals which promote neuronal differentiation may
also make the cell dependent upon growth factors for sur-et al., 1994, 1996). Although cooperative interactions with
adjacent rhombomeres are required to induce regional vival. Alternatively, these different facets of neuronal devel-
opment may be regulated separately. In fact, this studyapoptosis, studies of dissociated cells have shown that only
r3 and r5 possess the intrinsic susceptibility to BMP4-medi- shows that treatment of MAH cells with BMP2 or BMP4
induces apoptosis in the absence of other growth factors.ated apoptotic signals (Graham et al., 1996).
Both the survival and the phenotypic commitment of However, treatment of MAH cells exposed to BMP2 with
bFGF and NGF fosters their survival and subsequent differ-neural stem/progenitor cells are regulated by the cellular
microenvironment, and some of the growth factors that entiation into neuron-like cells even in the continuing pres-
ence of BMP2. Thus, the requirement for a growth factor tomay be involved in lineage decisions have been identi®ed
recently. For example, multipotent neural crest progenitor prevent apoptosis may re¯ect not only programmed cellular
dependence, but also the presence of another proapoptoticcells give rise to most of the peripheral nervous system
including neurons, Schwann cells, skin melanocytes, and a factor in the cellular environment. Such a mechanism may
facilitate selective segmental or regional trimming of cellvariety of mesectodermal derivatives such as smooth mus-
cle cells (LeDouarin, 1981). Transplantation and cell culture populations, such as is observed during the formation of
rhombomeres under the in¯uence of BMP4 (Graham et al.,studies have shown that commitment of neural crest cells
to these various phenotypes is in¯uenced by extracellular 1994, 1996).
signals (LeDouarin et al., 1980). Treatment of cultured neu-
ral crest progenitors with neuregulin/GGF promotes glial
differentiation, whereas treatment with bone morphogene- MATERIALS AND METHODS
tic protein 2 (BMP2) promotes neuronal differentiation, and
treatment with transforming growth factor b1 stimulates 1. Cell Culture
differentiation into smooth muscle cells ( Shah et al., 1994,
MAH cells were cultured as previously described (Birren and1996). The effects of these growth factors are context-depen-
Anderson, 1990) in L-15 CO2 medium containing 10% fetal bovinedent (i.e., different fates may be induced by the same growth
serum and 5 mM dexamethasone at 377C in a humidi®ed 5% CO2factor when cells are exposed to different environments).
incubator. Cells (1.5±3 1 104) were used for all experiments exceptThus, BMP2 induces catecholaminergic traits in neural
when otherwise stated. The cells were plated on poly-D-lysine- (20
crest cells under some circumstances (Reissmann et al.,
mg/ml) and laminin- (10 mg/ml) coated 24-well plates. All treat-
1996) but not others (Shah et al., 1996). Moreover, BMP2 ments were given 2 h after plating unless otherwise stated. rhBMP2,
may induce different lineage decisions in different progeni- rhBMP4, and rhBMP7 were generous gifts of Genetics Institute Inc.
tor cells. For example, treatment of cultured embryonic and (Cambridge, MA); rhNGF was a gift from Genentech Inc. (South
neonatal subventricular zone progenitor cells with BMP2 San Francisco, CA); and bFGF was obtained from Collaborative
Biomedical, Inc. The ICE inhibitor (Z-VAD-Ch2F) was obtainedleads to astrocytic differentiation and actually suppresses
from Kamiya Biomedical Co. (Seattle, WA). Aurintricarboxylic acidneuronal differentiation (Gross et al., 1996); BMP2 treat-
(ATA) was purchased from Sigma Chemical Co.ment also promotes astrocytic differentiation from embry-
onic stem cells (D'Alessandro and Wang, 1994; D'Alessan-
dro et al., 1994). Similarly, BMP2 induces the neuron-associ-
2. Immunoblottingated basic-helix-loop-helix transcription factor MASH1 in
some cells (Shah et al., 1996) but suppresses MASH1 in MAH cells (106) were suspended in lysis buffer [Triton X-100
(1%), SDS (0.1%), deoxycholate (1%), iodoacetamide (1 mM), apro-others (Sasai et al., 1995; Wilson and Hemmati-Brivanlou,
tinin (0.2 mM); phenylmethylsulfonyl ¯uoride (1 mM), Tris±HCl1995; Simpson, 1995), possibly depending upon the stage of
(0.01 M pH 8.0), NaCl (0.14 M), NaN3 (0.025%)] and shaken at 47Cdevelopment. Growth factors other than BMP2 have also
for 1 h. Insoluble debris was removed by microcentrifugation atbeen implicated in neuronal differentiation of neural crest
10,000 rpm for 10 min. The protein mixture was loaded onto anprogenitor cells. Treatment with basic ®broblast growth
8% SDS±PAGE gel and following electrophoresis was transferredfactor (bFGF) promotes neuronal differentiation of MAH
to nitrocellulose membrane. The membrane was probed with
cells, a clonal cell line derived by retroviral immortalization BMPR-IA, BMPR-IB, and BMPR-II antibodies (gifts from Dr. K.
of a rat embryonic sympathoadrenal progenitor cell (Birren Miyazono, Cancer Institute, Tokyo, Japan) for 1 h at room tempera-
and Anderson, 1990). bFGF treatment of these cells also ture. The secondary antibody (rabbit anti-mouse IgG) was added
induces responsiveness to nerve growth factor (NGF) (Birren for 1 h and the blots were developed using ECL reagent (Amersham,
Arlington Heights, IL) following the manufacturer's instructions.and Anderson, 1990). Further, ciliary neurotrophic factor
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3. Immunoprecipitation
MAH cells were labeled with 35S Met/Ser (ICN Pharmaceuticals)
in DMEM without methionine/serine (Sigma) for 2 h at 377C in a
humidi®ed 5% CO2 incubator and were lysed in lysis buffer at 47C
for 1 h. 106 cpm of supernatant was incubated with BMPR-IA or
BMPR-IB antibodies in dilution buffer [Triton X-100 (0.1%), bovine
hemoglobin (0.1%), Tris±Cl (0.01 M, pH 8.0), NaCl (0.14 M), NaN3
(0.025%)] at 47C for 1.5 h. Protein G±Sepharose (Pharmacia Bio-
tech.) was added and the mixture was shaken on a rotary shaker
at 47C for 1.5 h. The Sepharose was washed ®ve times in lysis
buffer, once in dilution buffer, and once in Tris±Cl (0.05 M, pH
7.5). Proteins were dissociated from the Sepharose by adding 20 ml
of SDS/sample buffer. Samples were then separated on an 8% SDS±
PAGE gel and visualized by autoradiography.
4. DNA Fragmentation
MAH cells (5 1 105) propagated on poly-D-lysine-coated 35-mm
dishes were treated with BMP2 (10 ng/ml) for 24 h. The cells were
then collected in lysis buffer [Tris±Cl (5 mM, pH 7.5), EDTA (20
mM, pH 8.0), Triton X-100 (0.5%)] and shaken for 20 min at 47C.
DNA was isolated by centrifugation at 10,000 rpm for 2 min and
extracted with phenol/chloroform. The DNA mixture was digested
with ribonuclease A and extraction with phenol/chloroform extrac-
tion was again performed. The pellets were dissolved in TE buffer
and DNA fragments were visualized as described previously (Kes-
sler et al., 1993).
FIG. 1. Treatment of MAH cells with selected BMPs induces cell
death. (A) MAH cells were treated with BMP2 (2.5 or 10 ng/ml) or
5. TUNEL Assay vehicle, and cell numbers were determined at 24-h intervals. BMP2
treatment resulted in a signi®cant decrease in cell number at 48 h
MAH cells (5 1 103) were plated onto individual wells of poly- and thereafter. *Differs from control at P 0.005 by ANOVA **Dif-
D-lysine-coated 24-well plates and were treated with rhBMP2 (5 fers from control at P  0.01 by ANOVA, N  5. Dose±response
ng/ml) for 16 h. The cells were ®xed with 4% paraformaldehyde pro®les for BMP2 treatment. (B) MAH cells were treated with differ-
for 30 min at room temperature, washed with PBS three times, and ent doses of BMP2 and cell numbers were determined 48 h later.
treated with Triton X-100 (0.5%) at room temperature for 10 min. Note the progressive decrease in cell number with increasing dose.
The cells were washed three times with water, with H2O2 (3%) for N  5. (C) MAH cells were treated with different doses of either
5 min, and then again with water at room temperature. The cells BMP4 or BMP7, and cell numbers were determined 48 h later. Note
were then incubated in TdT buffer containing terminal transferase that BMP7 failed to alter cell numbers, whereas there was a dose-
(0.3 ml/ml) and biotin-16-dUTP (40 mM) (Boehringer-Mannheim) at dependent decrease in cell numbers after BMP4 treatment. N  5.
room temperature for 30 min, followed by TB buffer (300 mM NaCl, (D) MAH cells were treated with BMP2 (10 ng/ml), bFGF (10 ng/
30 mM Na citrate) at room temperature for 15 min. After washing ml) plus NGF (100 ng/ml), or BMP2 plus bFGF and NGF. Note that
with PBS, the cells were immersed in BSA (1%), nonfat dry milk BMP2 treatment alone signi®cantly reduced cell numbers, whereas
(0.2%), and Triton X-100 (0.2%) in PBS at room temperature for 30 combined BMP2 / bFGF / NGF treatment did not differ signi®-
min, washed with PBS three times, and visualized using a DAB cantly from control. ***P  0.001 by ANOVA, N  5.
peroxide substrate kit (Vector Laboratories, Inc., Burlingame, CA).
RESULTS Morphologically, the treated cells became progressively
smaller and more pyknotic until only small ghosts of cell
membrane remained (Figs. 2B and 4B). A signi®cant reduc-To examine the effects of BMP2 on MAH cell survival,
cultures were treated with either 2.5 or 10 ng/ml of the tion in cell number was noted with doses as low as 0.1 ng/
ml (Fig. 1B), with 50% reduction at 4 days at a dose of 1cytokine or with vehicle (control), and cell numbers were
quanti®ed over the next 96 h (Fig. 1). Viability was deter- ng/ml. Treatment with BMP4, another member of the dpp
subgroup (for review see Mehler et al., 1997), also reducedmined by morphologic criteria during the ®rst 72 h (pres-
ence of an intact cell membrane) and by dye exclusion at cell numbers with a dose±response relationship similar to
BMP2 (Fig. 1C). By contrast, treatment with BMP7 did not96 h. Cell numbers increased ®vefold in control cultures
(Figs. 1 and 2A) over the 96-h period. By contrast, treatment alter survival (Fig. 1C), indicating that the cellular effects
are BMP-subclass speci®c.with 2.5 ng/ml BMP2 signi®cantly reduced the overall cell
number by more than 70%, and treatment with 10 ng/ml Since the cells died after exposure to BMP2, we ques-
tioned whether this re¯ected development of dependenceof the factor reduced the cell number by more than 95%.
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FIG. 2. Effects of combined treatment with BMP2, bFGF, and NGF. Cells were treated with BMP2, bFGF plus NGF, or BMP2 plus bFGF
and NGF and were photographed 48 h later. (A) Control (vehicle-treated) cells. (B) BMP2 (10 ng/ml). (C) BMP2 (10 ng/ml) / bFGF (10 ng/
ml) / NGF (100 ng/ml). (D) bFGF (10 ng/ml) / NGF (100 ng/ml). Note that BMP2 treatment alone (B) resulted in cell death compared to
control (A). bFGF / NGF treatment (D) promoted differentiation of cells into neuron-like morphology with extensive process outgrowth.
Combined treatment with bFGF and NGF along with BMP2 (C) protected against cell death and resulted in a morphologic phenotype
similar to bFGF / NGF alone, although there was somewhat greater clustering and less process outgrowth.
on other growth factors for survival. The cells were there- of MAH cells treated with BMP2 (Figs. 1D and 2C). Thereaf-
ter, the cells differentiated into neuron-like cells as pre-fore treated with bFGF and NGF after exposure to BMP2.
Treatment with bFGF and NGF rescued approximately 75% viously reported (Birren and Anderson, 1990; see Fig. 2D).
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Treatment of MAH cells with bFGF and NGF alone induced
differentiation into neuron-like cells without signi®cantly
altering survival after 4 days in culture (Fig. 1D). Exposure
of the cells to BMP2 for less than 6 h with subsequent
removal of the factor failed to kill the cells. However, more
than 6 h of exposure led to death of the cells even if BMP2
was removed. However, if cells exposed to BMP2 for more
than 6 h (6±18 h) were treated with FGF/NGF, they sur-
vived, indicating that they had become dependent upon
these factors for their survival even in the absence of
continuing exposure to BMP2. Thus, BMP2 treatment of
the cells induced dependence on other growth factors for
survival.
The progressive shrinkage and pyknosis of cells treated
with BMP2 suggested an apoptotic mechanism of death.
Internucleosomic cleavage of DNA with ``laddering'' and
TUNEL labeling are characteristic features of apoptosis.
Cells treated with BMP2 for 24 h were therefore examined
for evidence of internucleosomic DNA cleavage (Fig. 3).
Southern gel analysis after BMP2 treatment demonstrated
laddering with bands separated in size by approximately 200
FIG. 4. BMP2-induced cell death is apoptotic. (A) MAH cells werebase pairs. By contrast, no laddering was seen in control
treated with either BMP2 (10 ng/ml) or vehicle in the presence of
cultures. Similarly, there was prominent TUNEL labeling different concentrations of the ICE inhibitor Z-VAD, and cell num-
of BMP2-treated cells, whereas control cells were devoid of bers were determined 48 h later. Note that increasing doses of the
label (Fig. 3). These observations, coupled with the morphol- ICE inhibitor resulted in progressive protection against the BMP2-
ogy of the dying cells, suggest apoptosis as the mechanism induced decrease in cell numbers. N 5. (B) MAH cells were treated
with either BMP2 (10 ng/ml) or vehicle in the presence of differentof BMP-mediated cell death. One of the main pathways
concentrations of ATA, and cell numbers were determined 48 hleading to apoptosis of many cell types involves a protease,
later. Note that concentrations of ATA greater that 1 mM decreasedsuch as the interleukin converting enzyme (ICE) or other
cell numbers, but combined treatment with ATA plus BMP2 par-members of a family of such proteases (caspases). Since ICE
tially protected cells from BMP2-induced death. N  5.inhibitors prevent apoptotic death of some cells (for review
see Martin and Green, 1995), the effects on BMP2-induced
cell death of z-VAD, an ICE inhibitor, were therefore exam-
ined (Figs. 4 and 5B). Treatment with the inhibitor at doses and 95% of control. There was diminished survival at lower
doses with a half-maximal effect at 75 mM and absence ofof 100 mM or greater increased cell numbers to between 75
signi®cant protection at doses of 10 mM or lower. Thus, the
ICE inhibitor signi®cantly inhibited BMP2-induced apop-
tosis. Endonuclease inhibitors, such as aurintricarboxylic
acid (ATA), also inhibit apoptosis of some cell types; the
effects of ATA on BMP2-induced death were therefore also
examined (Fig. 5C). ATA treatment itself at doses greater
than 10 mM reduced cell numbers to about 50% of untreated
controls. However, ATA treatment of BMP2-treated cul-
tures increased cell numbers to approximately 50% of un-
treated controls, a level indistinguishable from treatment
with ATA alone. Thus, despite some apparent toxicity,
ATA treatment partially prevented BMP2-induced cell
death.
Although the receptors which mediate BMP actions have
not yet been fully characterized, several receptor subunits
FIG. 3. BMP2-induced cell death involves DNA fragmentation have been recently identi®ed. BMP-speci®c receptor sub-
with DNA ``laddering'' and TUNEL labeling. MAH cells were units expressed by MAH cells were therefore examined by
treated with BMP2 (10 ng/ml) or vehicle, and 24 h later DNA was Western blot analysis (Fig. 6A). MAH cells expressed both
examined by Southern blot analysis. Note the characteristic pattern
type I receptor subunits, BMPR-1A and BMPR-1B, as wellof internucleosomic cleavage (laddering) of DNA after BMP2 treat-
as the type II subunit, BMPR-II (for review see Mehler etment. Some cells were also examined for TUNEL labeling (right
al., 1997). Although fully quantitative comparisons of levelsside of ®gure). Note that BMP2 treatment resulted in signi®cant
of expression of the subtypes were not done, the BMPR-IITUNEL staining (bottom cells), whereas control cells (top cells)
were unlabeled. and BMPR-1B subunits appeared to be more abundant than
Copyright q 1998 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8847 / 6x3a$$$$61 03-23-98 12:02:22 dbal
124 Song, Mehler, and Kessler
FIG. 5. Effects of combined treatment with BMP2 and an ICE inhibitor. Cells were treated with vehicle (A), BMP2 (10 ng/ml) (B), BMP2
plus Z-VAD (100 mM) (C), or Z-VAD alone (D) and were photographed after 48 h. Note that BMP2 treatment alone (B) resulted in cell
death, but addition of the ICE inhibitor along with BMP2 (C) protected the cells from BMP-induced death.
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veloping embryos may re¯ect the combined in¯uences of
proapoptotic and antiapoptotic cytokines.
This study has demonstrated that treatment of MAH cells
with either BMP2 or BMP4 leads to cell death in a dose-
related manner. Was the mechanism of cell death apoptotic
rather than necrotic? MAH cell death displayed many char-
acteristics typical of apoptosis, including progressive
shrinkage and pyknosis, endonucleosomic cleavage of DNA
(laddering as well as TUNEL labeling), prevention by inhibi-
tion of ICE proteases, and partial prevention by the endonu-
clease inhibitor ATA. Further, several previous studies have
demonstrated BMP-induced apoptosis both within the ner-
vous system and in other organs (Graham et al., 1994; Ho-
gan, 1996). These observations strongly suggest that the
MAH cells died through apoptotic mechanisms. The precise
FIG. 6 Expression of BMP receptor subunits by MAH cells. (A)
pathways mediating BMP-induced apoptosis are unclear, al-MAH cells (M) or control whole adult brain cells (C) were examined
though the inhibition of death by an ICE protease inhibitorby Western blot analysis for the presence of BMP receptor subunits.
suggests involvement of these proteases.Note that MAH cells express the BMPR-IA, BMPR-IR, and BMPR-
Our ®ndings with MAH cells are consistent with priorII subunits. (B) MAH cells were labeled with [35S]methionine/serine
observations regarding the effects of the BMPs on rhomben-for 2 h, lysed, and immunoprecipitated with antibodies to either
BMPR-IA or BMPR-IB. Note that both type I receptor subunits were cephalic neural crest (Graham et al., 1994, 1996), but are at
detected, con®rming the Western blot analysis. variance with evidence suggesting that the BMPs promote
neuronal differentiation of sympathoadrenal progenitor
cells (Shah et al., 1996). There are several possible explana-
tions for this apparent discrepancy. First, isolation and prep-
BMPR-1A in MAH cells. By contrast, BMPR-1A appeared aration of neural crest progenitors involve culture of cells
more abundant in adult whole brain (control). Immunopre- in the presence of 10% chick embryo extract (Stemple and
cipitation followed by Western analysis con®rmed the pres- Anderson, 1992) which contains signi®cant levels of bFGF
ence of both type I subunits in MAH cells (Fig. 6B). and many other growth factors. Since our observations sug-
gest that bFGF both protects against BMP-induced apoptosis
and affects the state of differentiation of the immortalized
DISCUSSION sympathoadrenal progenitors, it is possible that prior obser-
vations about BMP effects on neural crest progenitors (Shah
et al., 1996) were in¯uenced by the exposure of the cells toDeveloping neurons become dependent upon exogenous
growth factors for survival, and the number of neurons in- bFGF and other components of chick embryo extract. It is
also possible that the discrepancy re¯ects differences in thenervating a target is regulated by the amount of growth
factor produced by the target. However, it has become in- developmental stage of the neural crest cells versus MAH
cells. Alternatively, it is possible that the process of immor-creasingly clear that mechanisms regulating cell number
in the developing nervous system are considerably more talization of the MAH cells has altered normal responses to
the BMPs. However increasing evidence that BMPs mediatecomplex and that neuron numbers may be determined not
only by factors which forestall cellular suicide, but also by apoptosis in the nervous system as well as other organs
(Graham et al., 1994, 1996; Hogan, 1996) suggests that ourfactors which promote cell death. Precedents exist in other
organ systems for such mechanisms of controlling cell num- observations are relevant to normal development. Further,
the dose±response relationship (Fig. 1) indicates that physi-bers. For example, thymic lymphocytes are induced to die
by adrenal corticoid hormones (Cohen and Duke, 1984), ologically appropriate levels of the BMPs are suf®cient to
induce apoptosis. The availability of a cell line which reli-cultured hepatocytes undergo apoptosis in the presence of
transforming growth factor b (Oberhammer et al., 1992), ably and reproducibly undergoes apoptosis in response to
BMPs will greatly facilitate analysis of the intracellularand treatment with tumor necrosis factor reportedly leads
to PCD of oligodendrocytes (Louis et al., 1993). Cytokine- pathways mediating this effect.
The survival of MAH cells after BMP treatment dependedinduced PCD of neurons has also been demonstrated pre-
viously; developing sympathetic neurons undergo apoptosis upon the presence of bFGF and NGF in the culture medium.
Conceptually this suggests a mechanism for regulating neu-in the presence of LIF or ciliary neurotrophic factor (CNTF)
(Kessler et al., 1993), and some neurons which express the ral progenitor cell numbers prior to their differentiation,
innervation of targets, and development of dependencep75LNTR receptor but not a member of the trk family die in
the presence of NGF (Frade et al., 1996). In the developing upon target-derived factors. Exposure of a population of pro-
genitor cells to a proapoptotic factor would transientlyrhombencephalon, the BMPs induce apoptosis of segments
r3 and r5, thus leading to segmentation (Graham et al., make them dependent upon another factor for their sur-
vival, and only those cells in the proper environment (i.e.,1994). These observations suggest that cell survival in de-
Copyright q 1998 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8847 / 6x3a$$$$61 03-23-98 12:02:22 dbal
126 Song, Mehler, and Kessler
Coughlin, M. D., Boyer, D. M., and Black, I. B. (1977). Embryologicexposed to the protective factor) would survive. How would
development of mouse sympathetic ganglion in vivo and in vitro.such a mechanism facilitate neural development? First, this
Proc. Natl. Acad. Sci. USA 74, 3438±3442.would provide a means for the general sculpting of the early
D'Alessandro, J. S., Yetz-Aldape, J., and Wang, E. A. (1994). Bonenervous system (e.g., segmentation as previously suggested;
morphogenetic proteins induce differentiation in astrocyte lin-Graham et al., 1994). Second, since the signals for differenti-
eage cells. Growth Factors 11, 53±69.
ation of progenitor cells may also be the ones that protect D'Alessandro, J. S., and Wang, E. A. (1994). Bone morphogenetic
them from undergoing apoptosis, it would provide a means proteins inhibit proliferation, induce reversible differentiation
of removing progenitor cells that do not encounter appro- and prevent cell death in astrocyte lineage cells. Growth Factors
priate signals for differentiation. Further, since susceptibil- 11, 45±52.
Davies, A. M. (1994). Intrinsic programs of growth and survival inity to BMP-induced apoptosis may be cell type-speci®c, it
developing vertebrate neurons. Trends Neurosci. 17, 195±199.would provide a means of selectively trimming some cell
Frade, J. M., Rodriguez-Tebar, A., and Barde, Y. A. (1996). Inductiontypes without affecting others. Finally, it would provide a
of cell death by endogenous nerve growth factor through its p75mechanism for removing cells that migrate errantly or that
receptor. Nature 383, 116±168.fail to differentiate fully. In this regard, it is noteworthy
Graham, A., Francis-West, P., Brickell, P., and Lumsden, A. (1994).that transient exposure of MAH cells to bFGF/NGF did not
The signalling molecule BMP4 mediates apoptosis in the rhomb-
protect them against BMP-induced death. encephalic neural crest. Nature 372, 684±686.
The BMPs may mediate a number of other functions in Graham, A., and Lumsden, A. (1996). Patterning the cranial neural
the nervous system, including dorsoventral patterning of crest. Biochem. Soc. Symp. 62, 77±83.
the developing nervous system, regulation of glial as well as Gross, R. E., Mehler, M. F., Mabie, P. C., Zang, Z., Santschi, L.,
and Kessler, J. A. (1996). Bone morphogenetic proteins promoteneuronal lineage commitment, and promotion of dendrite
astroglial lineage commitment by mammalian subventricularoutgrowth from peripheral as well as central nervous sys-
zone progenitor cells. Neuron 17, 595±606.tem neurons (for review see Mehler et al., 1997). Thus, the
Hogan, B. L. (1996). Bone morphogenetic proteins: Multifunctionalproapoptotic effects are clearly temporally regulated and/
regulators of vertebrate development. Genes Dev. 10, 1580±1594.or cell type-speci®c. There is precedent for the temporal
Ip, N. Y., Boulton, T. G., Li, Y., Verdi, J. M., Birren, S. J., Anderson,regulation of neuronal susceptibility to the proapoptotic ef-
D. J., and Yancopoulos, G. D. (1994). CNTF, FGF, and NGF col-
fects of cytokines. Treatment of embryonic and postnatal laborate to drive the terminal differentiation of MAH cells into
sympathetic neurons with LIF or CNTF induces apoptosis. postmitotic neurons. Neuron 13, 443±455.
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